La dengue

Medecine/Sciences

Volumn 18, Issue 8-9, 2002, Pages 816-818

  Flamand, Marie ^a   Després, Philippe ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84888792388     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20021889816     Document Type: Article

References (13)

1. st century. Trends Microbiol 2002; 10: 100-3.
2. McBride WJ, Bielefeldt-Ohmann H. Dengue viral infections; pathogenesis and epidemiology. Microbes Infect 2000; 2: 1041-50.
3. Guzman MG, Kouri G. Dengue: an update. The Lancet Infect Dis 2002; 2: 33-42
4. Clarke, T. Break-bone fever. Nature 2002; 416: 672-74.
5. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Orndam AV. Dengue and dengue haemorrhagic fever. Lancet 1998; 352: 971-7.
6. Flamand M, Despres P., Flaviviridae I. In: Hureaux JF, Nicolas JC, Dupin A, eds. Les Flavivirus. Virologie médicale. Paris: Éditions ESTEM 2002 (sous presse).
7. Kuhn RJ, Zhang W, Rossman MG, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002; 108: 717-25.
8. Deubel V, Flamand M, Marianneau P, Desprès P. Les flavivirus responsables de fièvres hémorragiques. Ann Institut Pasteur/Actualités 1997; 8: 285-95.
9. Kurane I, Takasaki T. Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large. Rev Med Virol 2001; 11: 301-11.
10. Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC. Immunopathogenesis of dengue virus infection. J Biomed Sci 2001; 8: 377-88.
11. Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology 1999; 257: 1-6.
12. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immun Med Microbiol 2000; 28: 183-8.
13. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002; 40: 376-81.